You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Active in life sciences? The Dutch Life Sciences Conference is a must!<br />
Meet the future – your future – at the Dutch Life Sciences<br />
Conference. The DLSC brings together creative entrepreneurs<br />
and expert investors. It’s the opportunity for top life<br />
scientists to find the business partners they need to realize<br />
their ambitions. Want to know what the sector’s next big<br />
success story is going to be? It’s a story you could be part<br />
of!<br />
23 November is your opportunity to rub shoulders with the<br />
sector’s movers and shakers at the DLS Conference in Lelystad’s<br />
Agora Theatre. To see and hear all about the very latest<br />
developments in this dynamic field. To make contact with the<br />
people and companies that can help you open the door to the<br />
future. Encounter new ideas. Expand your network. Engineer<br />
opportunities.<br />
Your next success story starts here<br />
Looking for new business partners? There’s no better place to<br />
find them than at the Dutch Life Sciences<br />
Conference. Everybody who is anybody<br />
will be there. From start-ups to big<br />
names in biopharma, medical devices<br />
and healthcare… from venture capitalists<br />
and business angels to leading research<br />
centres.<br />
Looking for a business partner?<br />
Make a presentation at the Investors Forum.<br />
The Forum represents a unique opportunity<br />
to spotlight your ideas in front<br />
of an audience of potential business<br />
partners. To meet investors who understand<br />
life sciences. To get their advice<br />
on the best strategy for bringing your<br />
plans to fruition. To move a step closer<br />
to realizing your dreams.<br />
Info www.dutchlifesciences.com<br />
Mark Straley<br />
benoemd tot CEO<br />
van Agendia<br />
Mark Straley benoemd tot CEO van<br />
Agendia Agendia ontwikkelt moleculair<br />
diagnostische kankertests (waaronder<br />
de borstkankertest MammaPrint®) en<br />
is leidend op het gebied van therapie op<br />
maat (personalised medicine). Agendia<br />
heeft de Amerikaan Mark Straley benoemd<br />
tot CEO. Straley volgt de Nederlander<br />
Jan Egberts op die vorig jaar<br />
oktober ad interim deze functie op zich<br />
nam.<br />
Straley heeft meer dan 25 jaar internationale<br />
ervaring in de ontwikkeling en<br />
commercialisatie van klinische diagnostiek<br />
en laboratoriumdiensten. Straley<br />
was President Anatomische Pathologie<br />
bij Thermo Fischer Scientific uit<br />
Waltham, Mass. in de VS. Daarvoor<br />
was hij CEO van Metamark Genetics<br />
(Cambridge, Mass.), een ontwikkelaar<br />
van prognostische en voorspellende diagnostische<br />
tests voor therapie op maat<br />
van kankerpatiënten.<br />
26
Change language